NCT02798328View on ClinicalTrials.gov

Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

CompletedOBSERVATIONAL
Enrollment

385

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
DOAC Eligible Subjects
Interventions
DEVICE

TEG6s DOAC Cartridge

Testing subjects for presence of DOAC

Trial Locations (4)

22042

Inova Health Care Services, Falls Church

29303

Spartanburg Regional Healthcare System, Spartanburg

46601

Memorial Hospital South Bend, South Bend

55805

Essentia Institute of Rural Health, Duluth

Sponsors
All Listed Sponsors
lead

Haemonetics Corporation

INDUSTRY